— Know what they know.
Not Investment Advice
Also trades as: OKYO.L (LSE) · $vol 0M · EMMLF (OTC) · $vol 0M

OKYO NASDAQ

OKYO Pharma Limited
1W: +6.5% 1M: -9.3% 3M: -8.7% YTD: -34.1% 1Y: -26.9% 3Y: -22.6%
$1.47
+0.13 (+9.70%)
 
Weekly Expected Move ±7.9%
$1 $1 $1 $2 $2
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 33 · $56.4M mcap · 21M float · 0.458% daily turnover · Short 40% of daily vol

📊 Key Metrics

TTM
$0M
Revenue
+0.0% YoY
$-11M
Net Income
-88924.7% YoY
$-8M
Free Cash Flow
-105677.3% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-213.7%
ROA-83.9%
ROIC128.1%

Valuation

P/E-6.1
P/B4.5
EV/EBITDA-2.4

Leverage

Debt/Equity0.00
Current Ratio2.43
Interest Cov.-28.7x

Quality Scores

Piotroski F3/9
Altman Z-7.82
Beneish M0.00

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms